Related Experiment Videos

DAPk protein family and cancer

Devrim Gozuacik1, Adi Kimchi

  • 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.

Autophagy
|December 5, 2006
PubMed

Insights

The Death-Associated Protein kinase (DAPk) family, including DAPk, ZIPk, and DRP-1, may form complexes to signal cell death. DAPk exhibits tumor suppressor properties, potentially through inducing autophagic cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Death-Associated Protein kinase (DAPk) family comprises three homologous serine/threonine kinases: DAPk, ZIPk, and DRP-1.
  • These kinases are involved in transmitting cell death signals, including apoptosis and autophagy, under cellular stress conditions like oncogene overexpression.

Purpose of the Study:

  • To review the connection between the DAPk protein family and cell death pathways.
  • To explore the role of DAPk in malignant transformation and its potential tumor suppressor functions.
  • To discuss how DAPk's autophagic cell death induction may contribute to its tumor suppressor activity.

Main Methods:

  • Literature review and data synthesis on DAPk family members.
  • Analysis of protein-protein interactions and kinase/substrate relationships.
  • Examination of evidence linking DAPk to tumor suppression and metastasis.

Main Results:

  • DAPk family members show high homology in catalytic domains.
  • Interactions suggest formation of multi-protein complexes for cell death signaling.
  • DAPk demonstrates tumor and metastasis suppressor properties.

Conclusions:

  • The DAPk family plays a significant role in regulating cell death and malignant transformation.
  • DAPk's capacity to induce autophagic cell death is a key mechanism underlying its tumor suppressor activity.
  • Further research into DAPk signaling pathways could offer therapeutic strategies for cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...